In 2019, Upsher-Smith Laboratories, a pharmaceutical company, planned to construct a new manufacturing facility at its Maple Grove headquarters. Since emissions for the expansion would require a Federal Part 70 permit, Upsher-Smith retained Barr to obtain an air permit prior to construction.
While the original facility did not contain any manufacturing operations, the new construction plans included full-scale batch production and a pilot plant for new product development. Barr helped Upsher-Smith strategize for compliance and operational flexibility by balancing the number of permit limits while still maintaining the ability to make process changes at the facility quickly. To achieve this, our team of environmental permitting experts minimized the use of Title 1 conditions and worked with the Minnesota Pollution Control Agency (MPCA) to put flexible language in the permit to better accommodate batch operations. We also helped our client navigate the complexities of the National Emissions Standards for Hazardous Air Pollutants (NESHAP) GGG federal standard.
The air permit for the new pharmaceutical manufacturing facility was issued in August 2020. Throughout construction and as the facility became operational in 2022, Barr also assisted with additional compliance services, including post-construction stack testing and emissions tracking.
(stock photo shown above)